A new study finds most people may not stay on GLP-1 drugs long enough to see their effects. Research from Blue Cross Blue Shield finds 58% of people taking liraglutide or semaglutide stopped using the ...
From sagging jowls and sulfurous burps to deflated breasts and surprise pregnancies, the side effects of GLP-1 weight-loss drugs have ranged from subtle to strange. Now, new research suggests that ...
There’s no doubt that GLP-1 drugs like Ozempic have been revolutionary — although the benefits do sometimes come with some unsightly downsides such as tooth decay, a droopy face or mouth, a saggy butt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback